Expanding access to shorter TB preventive treatments is saving lives. Through price reductions of up to 80% and support to countries, people in more than 100 countries can now access best-in-class prevention.

Find out more: unitaid.org/uploads/Unitaid-and-Tube...

Expression of Interest: Call for Community and Civil Society Representatives to serve on the Regional Manufacturing for Equitable Access Portfolio Advisory Committee - Unitaid

Community and civil society voices are vital to equitable access. Unitaid is seeking representatives to join the Regional Manufacturing for Equitable Access Portfolio Advisory Committee and help guide the portfolio.

Learn more: https://ow.ly/p0ah50YwiJO

Expression of Interest: Call for Membership in the Regional Manufacturing for Equitable Access Community of Informed Partners - Unitaid

Unitaid invites stakeholders to join the Regional Manufacturing for Equitable Access Community of Informed Partners, supporting dialogue, coordination and information sharing to advance equitable access to health products.

Learn more: https://unitaid.org/news-blog/EOI-20260316a

The TB response must work for everyone – including those it has historically overlooked - Unitaid

#WorldTBDay #YesWeCanEndTB

The TB response won’t succeed if it leaves people behind. Millions are still missed. Equity must be at the centre. It’s not just about new tools but who they reach.

@unitaid.bsky.social @unitaidcommunities.bsky.social @kelinkenya.bsky.social

unitaid.org/news-blog/th...

🚨 Reminder: Join our Maternal & Newborn Health Learning Session on 19 March 2026

Speakers:

- Olayide Akanni, NGO Delegation Board member
- Patricia Asero, ICW Kenya
- Jeff Smith, Unitaid
- Dr. Yogesh Rajkotia, ThinkWell
- Bahati Haule, AFROCAB

Register here: us06web.zoom.us/meeting/regi...

📢 Save the date: Maternal & Newborn Health Learning Session

Join the NGO & Communities Delegations for a civil society learning session on the MNH landscape, access gaps, and opportunities for action.

🗓 19 March 2026
🕒 15:00-16:30 CET
🔗 Register: us06web.zoom.us/meeting/regi...

United Kingdom review reaffirms Unitaid’s impact as a “critical enabler” of global health, awards A+ rating - Unitaid

A new UK Government review says Unitaid is a critical enabler of global health, helping bridge the gap between breakthrough products and the people who need them most. For the second year running, the UK's FCDO awarded Unitaid an A+ rating.

Read more: unitaid.org/news-blog/un...

Unitaid seeks to address the systemic barriers that undermine access to critical maternal and newborn health products with new funding opportunity - Unitaid

We’re launching a new funding opportunity to tackle systemic barriers limiting access to life-saving maternal and newborn health products in low- and middle-income countries. Deadline to apply: 20 March 2026.

Learn more: unitaid.org/news-blog/un...

Unitaid approves new investments to accelerate equitable access to lenacapavir for HIV prevention - Unitaid

More good news in the rollout of #lenacapavir for #HIV #PrEP: @unitaid.bsky.social will give funding to SA + Zambia to broaden access, unitaid.org/news-blog/un...

Another step forward in rolling #LEN out with speed, scale and equity. For the latest on LEN: avac.org/lenacapavir/

Accelerating Cervical Cancer Elimination through Secondary Prevention in Low- and Middle-Income Countries - Unitaid

🔇New Unitaid Call for Proposals:

Accelerating Cervical Cancer Elimination through Secondary Prevention in Low- and Middle-Income Countries

Deadline: 9 April 2026 (12:00 CET)

unitaid.org/call-for-pro...

Join the NGO & Communities Delegation to the @unitaid.bsky.social Board at #ICASA2025 to discuss Unitaid & the future of HIV access!

Date: Thursday 4 December 2025
Time: 15:00-16:00 (Accra)

@unitaidcommunities.bsky.social
@unitaidngos.bsky.social

@unitaid.bsky.social

As malaria continues to affect millions, new science offers hope. Our new report shows how genetically modified mosquitoes can move from research to responsible use, helping countries prepare for equitable, evidence-based deployment. More from @mggalvin.bsky.social: www.euronews.com/health/2025/...

🔈NGO & Communities Delegations Celebrate Unitaid’s Success in Accelerating Affordable Access to Long-Acting Lenacapavir for PrEP at a price of US$40 per person per year.

See statement:

unitaidngodelegation.org/2025/09/24/u...

@unitaid.bsky.social
@unitaidcommunities.bsky.social
CHAI
WITS RHI

@unitaid.bsky.social @unitaidcommunities.bsky.social

@unitaid.bsky.social @unitaidcommunities.bsky.social

🔈Unitaid NGO & Communities Delegations Celebrate Unitaid’s Success in Accelerating Affordable Access to Long-Acting Lenacapavir for PrEP at a price of US$40 per person per year - just two years after first approvals.

unitaidngodelegation.org/2025/09/24/u...

Register to join our co-ed Florence Anam alongside @unitaid.bsky.social and @kelinkenya.bsky.social leaders on tomorrow's webinar focusing on Community-Driven Regional Manufacturing for HIV Response.

Date: 15 July 2025
Time: 2-3:30
Register here: us06web.zoom.us/webinar/regi...

🔊Reminder to sign up below for our upcoming webinar with
@unitaidcommunities.bsky.social @oneillinstitute.bsky.social

'The Road to Long-Acting Antiretroviral Therapy'

Thursday 17 April
3-4:30pm SAST & CET

💻 georgetown.zoom.us/webinar/regi...